Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC Buildings B and C.” We noted in this example that, under the proposed definition of the “office of the billing physician or other supplier,” the anti-markup payment limitation would not apply to diagnostic testing services provided in Building B, but would apply to those services provided in Building C. The commenter stated that it agreed with our conclusion, if the ordering physician or supplier’s services were provided in Building B. According to the commenter, if the ordering physician provided his or her services in Building A, the anti-markup provisions should apply. Response: We do not agree with the commenter’s assertion that our revisions to §414.50(a)(2)(iv) undermine the anti-markup provisions and enable “pod labs” to regain their ability to facilitate markups. In particular, we refer the reader to the definition of the “office of the building physician or supplier” at §414.50(a)(2)(iv), which includes space in which diagnostic testing services are performed, that is in the “same building,” (as defined at §411.351), in which the ordering physician or ordering supplier regularly furnishes patient care (and more specifically, for physician organizations, in the same building in which the ordering physician provides substantially the full range of patient care services that 476
CMS-1403-FC the ordering physician provides generally). Many of the potentially abusive pod lab arrangements that led to our extension of the anti-markup provisions to the PC of diagnostic testing services involved independent contractor pathologists who performed services in off-site pathology labs. Those arrangements did not have the type of nexus with the group practice required under §414.50(a)(2) (that is, the pod labs were not within the same building in which the ordering physician provided substantially the full range of patient care services). We do agree with the commenter’s analysis of Example 3 given in the proposed rule. Comment: One commenter requested that, if adopted, the proposal for Alternative 2 should include detailed examples that provide clear definitions for several key terms, including “office of the billing physician or other supplier,” “conducting and supervising the TC,” and “full range of services.” The commenter believes that, without these definitions, our intent will be misconstrued and subject to potential abuse. Response: We do not provide a definition for “conducting and supervising the TC” in the regulation text, as we believe that the meaning of “conducting” is clear on its face; that is, the term “conducting the TC” refers to 477
- Page 425 and 426: CMS-1403-FC numerical test for the
- Page 427 and 428: CMS-1403-FC space in which the orde
- Page 429 and 430: CMS-1403-FC disadvantage nonproblem
- Page 431 and 432: CMS-1403-FC would be simpler to not
- Page 433 and 434: CMS-1403-FC IDTF standards in §410
- Page 435 and 436: CMS-1403-FC that rule, the Governme
- Page 437 and 438: CMS-1403-FC with comment period, th
- Page 439 and 440: CMS-1403-FC 1842(n)(1) of the Act,
- Page 441 and 442: CMS-1403-FC anti-markup provisions
- Page 443 and 444: CMS-1403-FC her group practice woul
- Page 445 and 446: CMS-1403-FC A commenter representin
- Page 447 and 448: CMS-1403-FC tenens arrangements cou
- Page 449 and 450: CMS-1403-FC other supplier. We are
- Page 451 and 452: CMS-1403-FC on pathology reports or
- Page 453 and 454: CMS-1403-FC patients. According to
- Page 455 and 456: CMS-1403-FC from sharing a practice
- Page 457 and 458: CMS-1403-FC Group A orders the TC a
- Page 459 and 460: CMS-1403-FC physicians the flexibil
- Page 461 and 462: CMS-1403-FC Response: We recognize
- Page 463 and 464: CMS-1403-FC Response: Because the d
- Page 465 and 466: CMS-1403-FC limited by the proposed
- Page 467 and 468: CMS-1403-FC Response: With respect
- Page 469 and 470: CMS-1403-FC to focus on the medical
- Page 471 and 472: CMS-1403-FC service” approach bec
- Page 473 and 474: CMS-1403-FC have the right to recei
- Page 475: CMS-1403-FC 2 approach finalized he
- Page 479 and 480: CMS-1403-FC ensure an adequate nexu
- Page 481 and 482: CMS-1403-FC entity” should be def
- Page 483 and 484: CMS-1403-FC between the performing
- Page 485 and 486: CMS-1403-FC supplier” to encompas
- Page 487 and 488: CMS-1403-FC to continue to provide
- Page 489 and 490: CMS-1403-FC requirements of the Alt
- Page 491 and 492: CMS-1403-FC supervised in the offic
- Page 493 and 494: CMS-1403-FC reducing access to care
- Page 495 and 496: CMS-1403-FC commenter supported ado
- Page 497 and 498: CMS-1403-FC “outside supplier,”
- Page 499 and 500: CMS-1403-FC group could recover onl
- Page 501 and 502: CMS-1403-FC incurred, thereby compe
- Page 503 and 504: CMS-1403-FC needed to provide the t
- Page 505 and 506: CMS-1403-FC performing supplier for
- Page 507 and 508: CMS-1403-FC providers, the services
- Page 509 and 510: CMS-1403-FC commenter also expresse
- Page 511 and 512: CMS-1403-FC overutilization of in-o
- Page 513 and 514: CMS-1403-FC provisions for single-s
- Page 515 and 516: CMS-1403-FC we did not propose such
- Page 517 and 518: CMS-1403-FC and PCs supervised or p
- Page 519 and 520: CMS-1403-FC provisions will not app
- Page 521 and 522: CMS-1403-FC (Pub. L. 110-173) (MMSE
- Page 523 and 524: CMS-1403-FC reporting data on quali
- Page 525 and 526: CMS-1403-FC PQRI and a more detaile
<strong>CMS</strong>-1403-FC<br />
Buildings B and C.” We noted in this example that, under<br />
the proposed definition of the “office of the billing<br />
physician or other supplier,” the anti-markup payment<br />
limitation would not apply to diagnostic testing services<br />
provided in Building B, but would apply to those services<br />
provided in Building C. The commenter stated that it<br />
agreed with our conclusion, if the ordering physician or<br />
supplier’s services were provided in Building B. According<br />
to the commenter, if the ordering physician provided his<br />
or her services in Building A, the anti-markup provisions<br />
should apply.<br />
Response: We do not agree with the commenter’s<br />
assertion that our revisions to §414.50(a)(2)(iv) undermine<br />
the anti-markup provisions and enable “pod labs” to regain<br />
their ability to facilitate markups. In particular, we<br />
refer the reader to the definition of the “office of the<br />
building physician or supplier” at §414.50(a)(2)(iv), which<br />
includes space in which diagnostic testing services are<br />
performed, that is in the “same building,” (as defined at<br />
§411.351), in which the ordering physician or ordering<br />
supplier regularly furnishes patient care (and more<br />
specifically, for physician organizations, in the same<br />
building in which the ordering physician provides<br />
substantially the full range of patient care services that<br />
476